7Baggers
 brokerages set y-mabs therapeutics, inc. (nasdaq:ymab) pt at $9.62  MarketBeat Fri, 19 Sep 2025 22:18:24 GMT
 SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics  GlobeNewswire Tue, 16 Sep 2025 07:00:00 GMT
 Y-Mabs Therapeutics Completes Merger with Perseus BidCo  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 Y-mAbs Therapeutics, Inc.(NasdaqGS: YMAB) dropped from S&P TMI Index  MarketScreener Tue, 16 Sep 2025 00:21:32 GMT
 published on: 2025-09-14 09:13:39  newser.com Sun, 14 Sep 2025 14:13:39 GMT
 y-mabs therapeutics, inc. (nasdaq:ymab) short interest update  MarketBeat Fri, 12 Sep 2025 03:55:10 GMT
 nuveen llc makes new investment in y-mabs therapeutics, inc. $ymab  MarketBeat Wed, 10 Sep 2025 22:29:13 GMT
 nuveen llc takes position in y-mabs therapeutics, inc. $ymab  MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 23:05:35  Newser Fri, 05 Sep 2025 04:05:35 GMT
 Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?  Zacks Investment Research Mon, 01 Sep 2025 07:00:00 GMT
 SERB to Acquire Y-mAbs Therapeutics for $412M  The Healthcare Technology Report. Wed, 27 Aug 2025 07:00:00 GMT
 about us  FinancialContent Tue, 26 Aug 2025 19:56:00 GMT
 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of  GlobeNewswire Tue, 26 Aug 2025 07:00:00 GMT
 shareholder investigation: halper sadeh llc investigates  GlobeNewswire Tue, 26 Aug 2025 07:00:00 GMT
 published on: 2025-08-26 05:03:47  mustnews.co.kr Mon, 25 Aug 2025 15:15:09 GMT
 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of  GlobeNewswire Thu, 21 Aug 2025 07:00:00 GMT
 star tribune  FinancialContent Thu, 21 Aug 2025 07:00:00 GMT
 about us  FinancialContent Thu, 21 Aug 2025 07:00:00 GMT
 y-mabs therapeutics investor alert by the former attorney  GlobeNewswire Wed, 20 Aug 2025 01:05:00 GMT

Y-mAbs Therapeutics, Inc
(NASDAQ:YMAB) 

YMAB stock logo

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophag...

Founded: 2015
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends